Phaseline

Companies › Biocodex

Biocodex: clinical trials, targets and expected readouts

2 active drug programs in 40 registered trials: 20 Phase 4, 12 Phase 3, 6 Phase 2, 2 Phase 1; Gastroenterology, Cardiovascular, Infectious disease, Oncology; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Amoxicillin (I-745)
Bacterial penicillin-binding protein inhibitor
–Phase 4Erythema Migrans of Lyme Disease; Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture); Helicobacter Pylori; Acute Coronary Syndrome …Dec 2026
Saccharomyces Boulardii CNCM I-745
Probiotic microorganism
–Phase 3IBS (Irritable Bowel Syndrome)–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT04047849Amoxicillin (I-745)Phase 4Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture)OtherJul 2021
NCT07122024Amoxicillin (I-745)Phase 4Helicobacter PyloriInfectious diseaseAug 2025
NCT06734260Amoxicillin (I-745)Phase 3Helicobacter Pylori Eradication RateInfectious diseaseNov 2025
NCT04728516Amoxicillin (I-745)Phase 4Acute Coronary SyndromeInfectious diseaseJun 2026
NCT07168434Saccharomyces Boulardii CNCM I-745Phase 3IBS (Irritable Bowel Syndrome)GastroenterologyOct 2026
NCT05957432Amoxicillin (I-745)Phase 2Helicobacter Pylori InfectionInfectious diseaseNov 2026
NCT06929962Amoxicillin (I-745)Phase 4Helicobacter Pylori InfectionInfectious diseaseDec 2026
NCT07451171Amoxicillin (I-745)Phase 2Small Intestine Bacterial OvergrowthInfectious diseaseDec 2026
NCT06451913Amoxicillin (I-745)Phase 4Erythema Migrans of Lyme DiseaseInfectious diseaseDec 2026
NCT06303128Amoxicillin (I-745)Phase 3Penicillin AllergyOtherDec 2026
NCT07894016Amoxicillin (I-745)Phase 4Wisdom Tooth RemovalOtherDec 2026
NCT07556991Amoxicillin (I-745)Phase 2Chronic Subdural HematomasCardiovascularDec 2026
NCT06823154Amoxicillin (I-745)Phase 1Allergy AmoxicillinOtherDec 2026
NCT06709196Amoxicillin (I-745)Phase 4CystectomyOncologyJan 2027
NCT06921213Amoxicillin (I-745)Phase 2Syphilis, CongenitalInfectious diseaseMar 2027
NCT06229288Amoxicillin (I-745)Phase 3Community-acquired PneumoniaRespiratoryMay 2027
NCT03031210Amoxicillin (I-745)Phase 2Community-acquired PneumoniaRespiratoryJun 2027
NCT06126731Amoxicillin (I-745)Phase 1Metastatic Castration-Resistant Prostate Cancer (mCRPC)OncologyJun 2027
NCT05846399Amoxicillin (I-745)Phase 4Cat BiteInfectious diseaseJul 2027
NCT06771492Amoxicillin (I-745)Phase 3MSK ConditionsOtherAug 2027
NCT05224401Amoxicillin (I-745)Phase 3Urinary Tract InfectionsInfectious diseaseSep 2027
NCT06929702Amoxicillin (I-745)Phase 4Amoxicillin-clavulanateOtherOct 2027
NCT07582549Amoxicillin (I-745)Phase 3Chronic CoughOtherDec 2027
NCT03966014Amoxicillin (I-745)Phase 3Erythema MigransInfectious diseaseDec 2027
NCT03966014Amoxicillin (I-745)Phase 3Erythema MigransInfectious diseaseDec 2027
NCT06877351Amoxicillin (I-745)Phase 3Syphilis AcquiredInfectious diseaseJan 2028
NCT07492134Amoxicillin (I-745)Phase 2Acute Uncomplicated DiverticulitisGastroenterologyApr 2028
NCT06020716Amoxicillin (I-745)Phase 4Protracted Bacterial BronchitisInfectious diseaseApr 2028
NCT06494072Amoxicillin (I-745)Phase 4Community Acquired Pneumonia in ChildrenRespiratoryMay 2028
NCT05761080Amoxicillin (I-745)Phase 4Laparoscopic AppendectomyGastroenterologyJun 2028
NCT07896239Amoxicillin (I-745)Phase 4Surgical Wound InfectionInfectious diseaseSep 2028
NCT06076304Amoxicillin (I-745)Phase 4Sinus InfectionInfectious diseaseOct 2028
NCT07275580Amoxicillin (I-745)Phase 4Autoimmune Rheumatic DiseasesInfectious diseaseJun 2029
NCT07576959Amoxicillin (I-745)Phase 3HELICOBACTER PYLORI INFECTIONSInfectious diseaseDec 2030
NCT07730814Amoxicillin (I-745)Phase 4Acute Otitis Media (AOM)OtherDec 2031
NCT07730814Amoxicillin (I-745)Phase 4Acute Otitis Media (AOM)OtherDec 2031
NCT07732699Amoxicillin (I-745)Phase 4ACUTE SINUSITISRespiratoryDec 2031
NCT07732699Amoxicillin (I-745)Phase 4ACUTE SINUSITISRespiratoryDec 2031
NCT02047994Amoxicillin (I-745)Phase 4Helicobacter Pylori InfectionsOncologyDec 2033
NCT01678027Amoxicillin (I-745)Phase 3Gastric CancerOncologyDec 2035

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Getz Pharma Dr. F. Köhler Chemie Albireo, an Ipsen Company Norgine Elgan Pharma

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.